Mettler-Toledo International has Most Pricing Power in Analytical Instruments Industry, RBC Says

MT Newswires Live

09/01

Mettler-Toledo International (MTD) has the most pricing power in the analytical instruments industry, RBC Capital Markets said in a Tuesday note.

A feature that differentiates Mettler-Toledo from some of its peers is its exposure to industries outside of biomedical research and production, which comprise about 45% of its sales, lower than the 60% average among peers, RBC said.

RBC said that while the mix difference didn't drive relative outperformance for Mettler-Toledo's stock during the 2024-2025 period of weakness in biomedical research, this trend now appears to be reversing.

Macro conditions support an acceleration in the company's organic sales growth in H2 and beyond, but this boost does not guarantee upside relative to companies more exposed to any biomedical research inflection, the firm said.

RBC initiated coverage on the stock with a sector perform rating and a $1,515 price target.

Price: 1387.40, Change: -17.74, Percent Change: -1.26

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2664850331"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2664850331\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2664850331?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-01 23:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2664850331","market":"nz","top_or_hot":-1,"title":"Mettler-Toledo International has Most Pricing Power in Analytical Instruments Industry, RBC Says","media":"MT Newswires Live","content":"<html><body><p> Mettler-Toledo International (MTD) has the most pricing power in the analytical instruments industry, RBC Capital Markets said in a Tuesday note.</p><p>A feature that differentiates Mettler-Toledo from some of its peers is its exposure to industries outside of biomedical research and production, which comprise about 45% of its sales, lower than the 60% average among peers, RBC said.</p><p>RBC said that while the mix difference didn't drive relative outperformance for Mettler-Toledo's stock during the 2024-2025 period of weakness in biomedical research, this trend now appears to be reversing.</p><p>Macro conditions support an acceleration in the company's organic sales growth in H2 and beyond, but this boost does not guarantee upside relative to companies more exposed to any biomedical research inflection, the firm said.</p><p>RBC initiated coverage on the stock with a sector perform rating and a $1,515 price target.</p><p>Price: 1387.40, Change: -17.74, Percent Change: -1.26</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mettler-Toledo International has Most Pricing Power in Analytical Instruments Industry, RBC Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMettler-Toledo International has Most Pricing Power in Analytical Instruments Industry, RBC Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-01 23:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Mettler-Toledo International (MTD) has the most pricing power in the analytical instruments industry, RBC Capital Markets said in a Tuesday note.</p><p>A feature that differentiates Mettler-Toledo from some of its peers is its exposure to industries outside of biomedical research and production, which comprise about 45% of its sales, lower than the 60% average among peers, RBC said.</p><p>RBC said that while the mix difference didn't drive relative outperformance for Mettler-Toledo's stock during the 2024-2025 period of weakness in biomedical research, this trend now appears to be reversing.</p><p>Macro conditions support an acceleration in the company's organic sales growth in H2 and beyond, but this boost does not guarantee upside relative to companies more exposed to any biomedical research inflection, the firm said.</p><p>RBC initiated coverage on the stock with a sector perform rating and a $1,515 price target.</p><p>Price: 1387.40, Change: -17.74, Percent Change: -1.26</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4533","symbol_name":"AQR资本管理(全球第二大对冲基金)","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2664850331","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2664850331","pubTimestamp":1788275415,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Mettler-Toledo International  has the most pricing power in the analytical instruments industry, RBC Capital Markets said in a Tuesday note.A feature that differentiates Mettler-Toledo from some of its peers is its exposure to industries outside of biomedical research and production, which comprise about 45% of its sales, lower than the 60% average among peers, RBC said.RBC said that while the mix difference didn't drive relative outperformance for Mettler-Toledo's stock during the 2024-2025 period of weakness in biomedical research, this trend now appears to be reversing.Macro conditions support an acceleration in the company's organic sales growth in H2 and beyond, but this boost does not guarantee upside relative to companies more exposed to any biomedical research inflection, the firm said.RBC initiated coverage on the stock with a sector perform rating and a $1,515 price target.Price: 1387.40, Change: -17.74, Percent Change: -1.26","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4121":"生命科学工具和服务","LU2211817866.USD":"Allianz Food Security AT Acc USD","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","IE00BFXG0V08.USD":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","IE00BYQQ9H92.USD":"BNY MELLON GLOBAL LEADERS \"A\" (USD) ACC","LU0347712357.USD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (USD) ACC","BK4588":"碎股","BK4585":"ETF&股票定投概念","IE00B5TLWC47.USD":"BNY MELLON LONG-TERM GLOBAL EQUITY \"B\" (USD) ACC","BK4567":"ESG概念","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","LU2413666426.HKD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (HKD) ACC","LU1721428933.USD":"法巴全球经典环境基金RH MD Dis","MTD":"梅特勒-托利多","BK4548":"巴美列捷福持仓","LU2413666699.HKD":"BNP PARIBAS GLOBAL ENVIRONMENT \"CRH\" (HKDHDG) INC"},"translate_title":"加拿大皇家银行表示，梅特勒-托利多国际公司在分析仪器行业拥有最大的定价权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MTD":1.5},"content_text":"Mettler-Toledo International (MTD) has the most pricing power in the analytical instruments industry, RBC Capital Markets said in a Tuesday note.A feature that differentiates Mettler-Toledo from some of its peers is its exposure to industries outside of biomedical research and production, which comprise about 45% of its sales, lower than the 60% average among peers, RBC said.RBC said that while the mix difference didn't drive relative outperformance for Mettler-Toledo's stock during the 2024-2025 period of weakness in biomedical research, this trend now appears to be reversing.Macro conditions support an acceleration in the company's organic sales growth in H2 and beyond, but this boost does not guarantee upside relative to companies more exposed to any biomedical research inflection, the firm said.RBC initiated coverage on the stock with a sector perform rating and a $1,515 price target.Price: 1387.40, Change: -17.74, Percent Change: -1.26","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}